Added-value of dynamic contrast-enhanced MRI to conventional MRI for the differentiation between inflammatory myofibroblastic tumor and squamous cell carcinoma in the sinonasal region
Purpose The purpose of this study was to evaluate the additional value of dynamic contrast-enhanced (DCE) MRI and diffusion weighted MRI (DWI) in differentiation between inflammatory myofibroblastic tumor (IMT) and squamous cell carcinoma (SCC) in the sinonasal cavity. Methods Patients with pathologically proven IMT and SCC in the sinonasal region were enrolled in this retrospective study. All participants underwent conventional MRI and dynamic contrast-enhanced MRI, while a subset of them performed DWI. All the MRI parameters were independently analyzed by two investigators. Results This retrospective study included 21 patients with IMT and 55 patients with SCC. Significant differences were found in the conventional MR imaging features including mass margin, T2 signal intensity and track sign of maxillary (p < 0.05). For DCE-MRI features, significant differences were found in progressive centripetal continual enhancement and CImax (p < 0.001 and p = 0.026, respectively). A marginal significant difference was found in ADC values between IMT (0.86 +/- 0.59) and SCC (1.14 +/- 0.25) (p = 0.061). The conventional MRI analysis revealed that the combination of mass margin and track sign of maxillary yielded an accuracy of 81.6%. Using a combination of progressive centripetal continual enhancement on DCE-MRI and track sign of maxillary in multivariate logistic regression analysis, the accuracy was elevated to 92.1%. Conclusion The incorporation of DCE-MRI features into conventional MRI showed improved diagnostic performance in differentiating IMT from SCC in the sinonasal region. The novel progressive centripetal continual enhancement on DCE-MRI is the most effective feature of IMT.
基金:
National Natural Science Foundation of China [82202100]; National Key R&D Program of China [2022YFC2404005]; Beijing Municipal Administration of Hospitals' Ascent Plan [DFL20190203]
语种:
外文
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类|3 区医学
小类|3 区临床神经病学3 区神经成像3 区核医学
最新[2023]版:
大类|3 区医学
小类|3 区临床神经病学3 区神经成像3 区核医学
JCR分区:
出版当年[2022]版:
Q3CLINICAL NEUROLOGYQ3NEUROIMAGINGQ3RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
最新[2023]版:
Q2CLINICAL NEUROLOGYQ2RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGINGQ2NEUROIMAGING
第一作者机构:[1]Capital Med Univ, Beijing Tongren Hosp, Dept Radiol, 1 Dongjiaominxiang St, Beijing 100730, Peoples R China[2]Xuzhou Med Univ, Affiliated Hosp, Dept Radiol, Xuzhou, Jiangsu, Peoples R China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Wang Qi,Wang Xinyan,Liu Hangzhi,et al.Added-value of dynamic contrast-enhanced MRI to conventional MRI for the differentiation between inflammatory myofibroblastic tumor and squamous cell carcinoma in the sinonasal region[J].NEURORADIOLOGY.2024,66(12):2281-2289.doi:10.1007/s00234-024-03498-6.
APA:
Wang, Qi,Wang, Xinyan,Liu, Hangzhi,Wang, Zhen&Xian, Junfang.(2024).Added-value of dynamic contrast-enhanced MRI to conventional MRI for the differentiation between inflammatory myofibroblastic tumor and squamous cell carcinoma in the sinonasal region.NEURORADIOLOGY,66,(12)
MLA:
Wang, Qi,et al."Added-value of dynamic contrast-enhanced MRI to conventional MRI for the differentiation between inflammatory myofibroblastic tumor and squamous cell carcinoma in the sinonasal region".NEURORADIOLOGY 66..12(2024):2281-2289